Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gribben

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2002
Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantationE Alyea, D Neuberg, P Mauch, et al.
Bone Marrow Transplantation|March 15, 2006
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantationV T Ho, H T Kim, D Liney, et al.
Bone Marrow Transplantation|December 4, 2003
Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effectE Alyea, E Weller, R Schlossman, et al.
Blood|January 7, 1998
Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantationA Freedman, D Neuberg, P Mauch, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Blood|August 9, 2001
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effectE Alyea, E Weller, R Schlossman, et al.
Leukemia|March 17, 2016
Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumabC L Freeman, M Dixon, R Houghton, et al.
Leukemia|February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemiaS Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia|August 15, 2017
Lamin B1 regulates somatic mutations and progression of B-cell malignanciesT Klymenko, J Bloehdorn, J Bahlo, et al.
Bone Marrow Transplantation|July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphomaR J Soiffer, A S Freedman, D Neuberg, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2002
Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantationE Alyea, D Neuberg, P Mauch, et al.
Bone Marrow Transplantation|March 15, 2006
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantationV T Ho, H T Kim, D Liney, et al.
Bone Marrow Transplantation|December 4, 2003
Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effectE Alyea, E Weller, R Schlossman, et al.
Blood|January 7, 1998
Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantationA Freedman, D Neuberg, P Mauch, et al.
Bone Marrow Transplantation|October 6, 2015
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomesR Vrhovac, M Labopin, F Ciceri, et al.
Blood|August 9, 2001
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effectE Alyea, E Weller, R Schlossman, et al.
Leukemia|March 17, 2016
Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumabC L Freeman, M Dixon, R Houghton, et al.
Leukemia|February 3, 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemiaS Pospisilova, D Gonzalez, J Malcikova, et al.
Leukemia|August 15, 2017
Lamin B1 regulates somatic mutations and progression of B-cell malignanciesT Klymenko, J Bloehdorn, J Bahlo, et al.
Bone Marrow Transplantation|July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphomaR J Soiffer, A S Freedman, D Neuberg, et al.
Pageof 6